16
Although they only left him ten percent of the shares, the interests represented by this ten percent were still staggering compared to the astronomical wealth that the new anti-cancer drug would create in the future.
If it were anyone else, they would either refuse, get their drug stuck by the Food and Drug Administration, unable to pass the review for a long time, resulting in billions in R&D funds going down the drain without recovering a single cent, or they would hand over the vast majority of the profits, keeping that ten percent share which would still be enough for them to make a fortune. I believe the vast majority of people would choose to surrender in such a situation!
However, this naturally does not include Chen Mo. Let alone ninety percent, Chen Mo would not give up even one percent of the shares!
"Trying to play this trick on me? You picked the wrong person!"
Chen Mo had heard the content of the other party's call clearly just now. Although the president of the Merck Pharmaceutical Group didn't say a single threatening word, when combined with the fact that their drug review had just been stalled by the Food and Drug Administration, this phone call was effectively a threat!
Either cooperate and give up most of the profits, or be completely blocked and not recover a single cent!
The fact that the other party could make the Food and Drug Administration change its stance and block them was enough to show the powerful influence they possessed; they naturally had the confidence to deal with SHIELD Bio's counterattack.
The Food and Drug Administration had not violated any regulations; they were simply following the rules. At most, one could say they were a bit rigid, and their starting point was, after all, for drug safety!
Even if it were taken to the media, it wouldn't have any impact on them. They would still need to conduct long-term clinical trials according to the regulations and then wait for further review.
At that point, they could easily continue to stall using various excuses. As long as Chen Mo did not compromise, SHIELD Bio would be completely blocked!
Chen Mo was almost certain that there was likely more to this matter than just the Merck Pharmaceutical Group!
But would Chen Mo be intimidated by others?
This was perhaps the only thing they had miscalculated!
"Send people to contact the health departments of China, Europe, and other countries. Tell them that we intend to open branches and build pharmaceutical factories in their countries to be the first to introduce this new anti-cancer drug to their markets!"
Chen Mo said calmly.
Upon hearing this, Su Wan's eyes lit up. How could she not have thought of that!
Generally, new drugs developed by pharmaceutical companies would first pass review in their home country before entering other countries, where the review process would be much simpler. Almost no one would bypass the near to seek the far, traveling to other countries to conduct the initial review of a drug.
However, this was a great solution for them. Since the U.S. Food and Drug Administration had blocked their new anti-cancer drug, they could simply go to other countries for review. Even if the U.S. didn't recognize the review results of other countries later, they could just abandon the U.S. market. The world was so big; it wasn't as if they couldn't survive without the U.S.!
Once their new anti-cancer drug was first launched in other countries and the actual results were seen, she wondered if these officials at the Food and Drug Administration would be drowned by the spittle of the American public!
As for the American public not being able to receive treatment, don't forget, Su Wan and Chen Mo were both Chinese!
When there was something good, naturally, they would prioritize their own compatriots. If the officials of your own country were courting disaster, there was nothing they could do!
Previously, conducting the review in the U.S. was just for convenience. Once the review was passed, neither Su Wan nor Chen Mo would forget their Chinese compatriots; they would inevitably introduce this drug to the Chinese market at the same time.
Now, they needed to conduct reviews in various countries again. Although this might lead to a delay in the drug's launch, China would inevitably remain their primary target. As for the U.S., which could have been among the first countries to benefit along with China, it was very likely to become the last country in the world to receive the new anti-cancer drug!
Feeling suddenly enlightened, Su Wan immediately began contacting the health departments of China, Europe, and other countries, expressing their intention to open branches and conduct drug reviews in each country.
Upon receiving the news, every country was pleasantly surprised—yes, pleasantly surprised!
Following reports by major U.S. media outlets, SHIELD Bio's new anti-cancer drug was already known to countries around the world. The health departments of various countries attached great importance to this drug, which had the potential to completely cure cancer. They had all sent people to investigate the clinical trial situation of this new anti-cancer drug and found that the media had not exaggerated and that SHIELD Bio had not falsified anything.
Comparing the medical analysis and examination results of these cancer patients before and after, the effect of the drug was clear at a glance; it had indeed inhibited the proliferation and spread of cancer cells. All the patients participating in the trial had shown significant improvement in their conditions, which was unimaginable for these patients, most of whom were in the late stages of cancer and could die at any moment!
However, under normal circumstances, this drug would inevitably pass review in the U.S. first, and only after obtaining a license would it be released to the global market. They only wanted to contact S.H.I.E.L.D. Technology to introduce this drug into their own countries as soon as possible after it passed the review.
As for having SHIELD Bio come to their countries for drug review, there had never been such a precedent before.
It was just like getting a driver's license; who wouldn't get their license in their hometown or where their school or company was located before driving to other places? Who would bypass the near to seek the far and travel a long way to another place just to get a driver's license?
But now, SHIELD Bio was doing exactly that!
Therefore, upon receiving the request from SHIELD Bio to establish branches and conduct drug reviews in their countries, every country was pleasantly surprised, because this meant that this new anti-cancer drug would be the first to be put into use in their countries!
Moreover, SHIELD Bio was not just setting up branches but also building factories in each country, which meant that this drug would transform from an import to a domestic product, avoiding high import and export tariffs, and the final selling price would be much cheaper!
Besides the tangible benefits that their own cancer patients could receive, this was also a huge political achievement for them!
They had no reason to refuse; on the contrary, they were all extremely enthusiastic, offering various preferential policies in the hope that SHIELD Bio would build factories and launch the product in their countries first.
Other countries that Su Wan had not contacted, such as India, Japan, and Australia, also took the initiative to contact SHIELD Bio after hearing the news, sending invitations one after another, hoping that SHIELD Bio would establish branches in their countries and promising to simplify the drug review process.
However, in reality, it was not necessary to conduct this review in every single country; as long as one country issued a drug license, the review in other countries would be much more convenient.
